Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

W. L. GORE & ASSOCIATES, INC

US

Last updated September 17, 2026

Information

Country
US
Address
1505 NORTH FOURTH ST., FLAGSTAFF, AZ, 86004
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
2017233
DUNS Number
—

Catalogue (1343)

Page 21 of 27
DeviceModel / ReferenceRegistriesClassStatus
GORE-TEX Suture 2N01
FDA UDI
Class IIActive
GORE VIABAHN Endoprosthesis VBC070202
FDA UDI
Class IIIUnknown
GORE-TEX Vascular Graft V07080L
FDA UDI
Class IIUnknown
GORE EXCLUDER AAA Endoprosthesis PXT311413
FDA UDI
Class IIIUnknown
GORE INTERING Vascular Graft IRST06040040L
FDA UDI
Class IIActive
GORE TAG Conformable Thoracic Stent Graft TGM343415
FDA UDI
Class IIIActive
GORE VIABAHN Endoprosthesis VBCR070501A
FDA UDI
Class IIIActive
GORE TAG Thoracic Endoprosthesis TGT3410
FDA UDI
Class IIIUnknown
GORE ENFORM Intraperitoneal Biomaterial GBFR1620
FDA UDI
Class IIActive
GORE DUALMESH Biomaterial 1DLMC04
FDA UDI
Class IIActive
GORE VIABAHN Endoprosthesis with Heparin VBJR050202A
FDA UDI
Class IIIActive
GORE INTERING Vascular Graft IRST07080080L
FDA UDI
Class IIActive
GORE PROPATEN Vascular Graft IRH060545A
FDA UDI
Class IIActive
GORE VIABAHN Endoprosthesis with Heparin VBHR050202A
FDA UDI
Class IIIActive
GORE EXCLUDER AAA Endoprosthesis PLL161407
FDA UDI
Class IIIActive
GORE Embolic Filter GEFA017300
FDA UDI
Class IIUnknown
GORE® DrySeal Flex Introducer Sheath GDSF2265
FDA UDI
Class IIActive
GORE SEAMGUARD Bioabsorbable Staple Line Reinforce 20055724
FDA UDI
Class IIActive
GORE CARDIOFORM ASD Occluder ASD37A
FDA UDI
Class IIIActive
GORE-TEX Vascular Graft RR47030070L
FDA UDI
Class IIUnknown
GORE VIABAHN Endoprosthesis VBC101002
FDA UDI
Class IIIUnknown
TIGRIS Vascular Stent PHA060802A
FDA UDI
Class IIIUnknown
GORE-TEX Stretch Vascular Graft-Bifurcated SBT1801D
FDA UDI
Class IIActive
TIGRIS Vascular Stent PHA061001A
FDA UDI
Class IIIUnknown
GORE EXCLUDER AAA Endoprosthesis PXT261212
FDA UDI
Class IIIUnknown
GORE-TEX Vascular Graft RRT07030070L
FDA UDI
Class IIUnknown
GORE DRYSEAL FLEX Introducer Sheath DSF2433
FDA UDI
Class IIActive
GORE-TEX Stretch Vascular Graft SA2002
FDA UDI
Class IIActive
GORE Embolic Filter GEFA015185
FDA UDI
Class IIUnknown
GORE-TEX Vascular Graft RR47050080NL
FDA UDI
Class IIUnknown
GORE-TEX Vascular Graft VT06070L
FDA UDI
Class IIActive
GORE VIABAHN Endoprosthesis with Heparin VBJR080202A
FDA UDI
Class IIIActive
GORE-TEX Vascular Graft RT08012030L
FDA UDI
Class IIUnknown
GORE INTERING Vascular Graft IRS06040L
FDA UDI
Class IIActive
GORE EXCLUDER AAA Endoprosthesis with C3 Delivery RLT231218
FDA UDI
Class IIIActive
GORE Hybrid Vascular Graft-CBAS 0650HYB0805A
FDA UDI
Class IIUnknown
GORE PRECLUDE MVP Dura Substitute 1MVP401
FDA UDI
Class IIUnknown
GORE EXCLUDER AAA Endoprosthesis with C3 Delivery RMT261216
FDA UDI
Class IIIUnknown
GORE EXCLUDER AAA Endoprosthesis PXC201200
FDA UDI
Class IIIUnknown
GORE-TEX Suture 6J12
FDA UDI
Class IIActive
GORE TAG Conformable Thoracic Endoprosthesis TGU404010
FDA UDI
Class IIIActive
GORE ENFORM Preperitoneal Biomaterial GBWR3040
FDA UDI
Class IIActive
GORE VIABAHN VBX Balloon Expandable Endo BXA072901A
FDA UDI
Class IIIActive
TIGRIS Vascular Stent PHA060801A
FDA UDI
Class IIIUnknown
GORE PROPATEN Vascular Graft H470080A
FDA UDI
Class IIActive
GORE-TEX Vascular Graft SRRT08070070L
FDA UDI
Class IIActive
GORE-TEX Vascular Graft VT07040L
FDA UDI
Class IIUnknown
GORE MYCROMESH PLUS Biomaterial 1MYMP10
FDA UDI
Class IIUnknown
GORE BIO-A Tissue Reinforcement HH0710
FDA UDI
Class IIActive
GORE-TEX Vascular Graft ST35005A
FDA UDI
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (28)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Aug 26, 2025Z-0036-2026—open, classified

Reports of vascular graft delamination, which may lead to reduced access flow; cannulation difficulties; bleeding or bruising; and harms related to reintervention procedures, so Instructions for Use will be updated to modify existing warning to 1) further clarify techniques that may contribute to the risk of delamination, 2) Addition of delamination to device-related adverse event section.

Jul 3, 2024Z-2513-2024—open, classified

Devices were labeled with an expiration date of four years and ten days rather than the validated two years.

Jul 1, 2024Z-2946-2024—open, classified

Due to packaging defects, sterility assurance and heparin activity may be compromised.

Jul 1, 2024Z-2945-2024—open, classified

Due to packaging defects, sterility assurance and heparin activity may be compromised.

Jan 19, 2024Z-1179-2024—open, classified

Devices without transmural drainage holes may be mislabeled as devices with transmural drainage holes, or vice versa. Potential health impact includes extending procedure time, unplanned device removal, secondary procedure, cholangitis, cholecystitis, and/or pain. The GORE VIABIL Short Wire Biliary Endoprosthesis is a flexible, self-expanding endoprosthesis designed to maintain luminal patency of the common bile duct which may be obstructed. The endoprosthesis is radially compressed and secured onto the distal end of a catheter-based delivery system for deployment. The catheter provides a means for accessing and implanting the GORE VIABIL Short Wire Biliary Endoprosthesis at the target site in the biliary tract.

Dec 14, 2022Z-1048-2023—open, classified

Septal Occluders released with incomplete quality test documentation that assesses the release of the device from the delivery system during the index procedure. A potential failure of this quality test could potentially result could result in occluder embolization, anoxic brain injury, central venous or arterial perforation or rupture.

Sep 21, 2022Z-0136-2023—open, classified

Due to manufacturing records (Release Test Results) indicating "Failed".

Sep 7, 2021Z-0077-2022—open, classified

Incorrect labeling, specifically, expandable endoprosthesis labeled as 8 mm x 59mm x 135 cm, however may contain a 9mm x 29 mm x 135 cm device.

Sep 2, 2021Z-0171-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0168-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0169-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0165-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0170-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0164-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0172-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0166-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Sep 2, 2021Z-0167-2022—open, classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Jul 12, 2021Z-2340-2021—open, classified

Complaints received concerning Balloon Catheter leakage from the guidewire lumen and the y-hub during preparation resulting in either insufficient inflation or an inability to inflate.

May 12, 2021Z-2293-2021—open, classified

Vascular Grafts containing an inner diameter of 6 mm may be incorrectly labeled as 5 mm and Vascular Grafts containing an inner diameter of 5 mm are incorrectly labeled as 6 mm.

May 12, 2021Z-2292-2021—open, classified

Vascular Grafts containing an inner diameter of 6 mm may be incorrectly labeled as 5 mm and Vascular Grafts containing an inner diameter of 5 mm are incorrectly labeled as 6 mm.

Apr 5, 2021Z-1593-2021—terminated

The Gore post market surveillance team received a complaint that a GORE VIABIL Biliary Endoprosthesis appeared shorter than the labeled length.

Sep 9, 2020Z-0290-2021—open, classified

Due to secondary deployment fiber being attached to secondary deployment handle, completion of deployment via the deployment line access hatch was not possible

Sep 9, 2020Z-0291-2021—open, classified

When the delivery catheter was attempted to be removed, there was an observed connection between the stent graft and the delivery catheter that prevented the delivery catheter from being withdrawn.

Jan 6, 2020Z-0996-2020—terminated

Firm has received reports of leading end catheter component separations.

Jan 6, 2020Z-0995-2020—terminated

Firm has received reports of leading end catheter component separations.

Dec 17, 2019Z-2052-2020—terminated

The incorrect label was placed on both the primary and secondary package.

Nov 18, 2019Z-1962-2020—terminated

The devices were mislabeled with the incorrect product size resulting in 16Fr devices being labeled as 14Fr devices.

Sep 25, 2017Z-0048-2018—terminated

Incomplete and/or partial deployment of the CTAG Device during the endovascular procedure.